BioCentury
ARTICLE | Financial News

Insmed files for follow-on

September 25, 2000 7:00 AM UTC

INSM, which is developing therapeutics to treat metabolic and endocrine diseases associated with insulin resistance, filed to sell 5 million shares in a follow-on offering underwritten by Robertson St...